<DOC>
	<DOCNO>NCT00713011</DOCNO>
	<brief_summary>The study consist 12 week run-in period subject stabilize single dose Avalide ( 300 mg/12.5 mg 300mg/25mg dose ) per day . After 12 week run-in end , subject randomly assign start addition either Adalat XL Tiazac XC 18 week treatment . Subjects 1 2 chance receiving study drug Adalat XL 1 2 chance receive drug Tiazac XC . An end treatment visit do 18 week start study drug . The expected duration study 30 week . The purpose study compare change proteinuria , urine test , take study drug high blood pressure ( BP ) reduce near normal level study subject diabetic nephropathy hypertension .</brief_summary>
	<brief_title>Adalat XL v Diltiazem Proteinuria Blood Pressure Hypertensive Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>&gt; /= 18 &lt; 80 year old . Diagnosed hypertension . Diagnosed diabetes mellitus type 2 least 6 mths prior entry stable medication diabetes 1 mth prior screen . Treated ARB , ACE inhibitor without hydrochlorothiazide suitable receive combination therapy Avalide 300mg/12.5mg per day 300mg/25mg per day . Diagnosed diabetic nephropathy proteinuria 0.8g/day 5.0g/day screen 0.8g/day 3.0g/day randomization . Medically appropriate receive Adalat XL Tiazac XC . History alcohol substance abuse . Significant CV disorder ischemic heart disease , arrhythmia within last 6 mths , history severe congestive heart failure . Myocarditis pericarditis within last 30 day screen . ECG show evidence major arrhythmia conduction disturbance require treatment antiarrhythmic medication . Females childbearing potential male partner childbearing potential unless willing use effective contraception study 3 mths end study . Females pregnant , lactate plan pregnancy study 3 mths study end . Known hypersensitivity Adalat XL Tiazac XC calcium channel blocker dihydropyridine class . Resting heart rate &lt; 50 &gt; 110 bpm . Presence secondary malignant hypertension . DBP &gt; /= 180 and/or SBP &gt; /= 110 mmHg .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Adalat XL</keyword>
	<keyword>Diltiazem</keyword>
	<keyword>Tiazac XC</keyword>
	<keyword>Proteinuria</keyword>
</DOC>